3M Drug Delivery Expands Manufacturing CapacityBy
3M Drug Delivery Systems Division is investing to improve and expand its pressurized metered dose inhalation (MDI) facility in Loughborough, UK. The investment, which will increase site capacity by more than 20%, comes two years after the company expanded the capacity of its MDI facility in Northridge, California.
The Loughborough investment will enable 3M to support growth in production for its existing commercial programs as well as newly committed developments. It will also bring the company extra capacity to meet future needs of branded and generic MDI markets. At the Northridge facility, the 2012 expansion added a pressure fill line to complement existing cold-fill capabilities.
Source: 3M Drug Delivery Systems Division